| Medical and Health Sciences | 2021-2025 | 713 | CN 71 | 99.84 |
| Environmental Science and Ecology | 2021-2025 | 473 | CN 222 | 99.57 |
| Obstetrics and Gynecology | Lifetime | 26 | CN 1 | 99.81 |
| Pediatrics, Perinatology and Child Health | Lifetime | 92 | CN 1 | 99.71 |
| Public, Environmental and Occupational Health | Lifetime | 915 | CN 16 | 98.67 |
| Health, Toxicology and Mutagenesis | Lifetime | 434 | CN 69 | 98.23 |
| Environmental Chemistry | Lifetime | 433 | CN 59 | 96.43 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 35 | CN 2 | 99.49 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 46 | CN 16 | 99.38 |
| Obstetrics and Gynecology | 2021-2025 | 35 | CN 3 | 99.20 |
| Environmental Chemistry | 2021-2025 | 41 | CN 25 | 98.42 |
| Public, Environmental and Occupational Health | 2021-2025 | 526 | CN 21 | 94.93 |
| Maternal and Perinatal Health Interventions | Lifetime | 20 | CN 1 | 99.72 |
| Pregnancy and preeclampsia studies | Lifetime | 67 | CN 4 | 99.57 |
| Gestational Diabetes Research and Management | Lifetime | 34 | CN 2 | 99.53 |
| Birth, Development, and Health | Lifetime | 115 | CN 2 | 99.47 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 74 | CN 1 | 99.31 |
| Maternal and fetal healthcare | Lifetime | 58 | CN 2 | 99.41 |
| Pregnancy-related medical research | Lifetime | 78 | CN 1 | 98.59 |
| Global Maternal and Child Health | Lifetime | 430 | CN 7 | 98.33 |
| Per- and polyfluoroalkyl substances research | Lifetime | 78 | CN 20 | 98.16 |
| Climate Change and Health Impacts | Lifetime | 493 | CN 61 | 96.78 |
| Pregnancy and Medication Impact | Lifetime | 317 | CN 3 | 96.54 |
| Effects and risks of endocrine disrupting chemicals | Lifetime | 869 | CN 115 | 95.82 |
| Preterm Birth and Chorioamnionitis | Lifetime | 564 | CN 7 | 93.28 |
| Birth, Development, and Health | 2021-2025 | 5 | CN 1 | 99.62 |
| Gestational Diabetes Research and Management | 2021-2025 | 4 | CN 1 | 99.56 |
| Pregnancy and preeclampsia studies | 2021-2025 | 40 | CN 6 | 98.81 |
| Per- and polyfluoroalkyl substances research | 2021-2025 | 34 | CN 12 | 97.65 |
| Effects and risks of endocrine disrupting chemicals | 2021-2025 | 64 | CN 24 | 97.32 |
| Reproductive System and Pregnancy | 2021-2025 | 155 | CN 59 | 95.15 |
| Air Quality and Health Impacts | 2021-2025 | 492 | CN 266 | 96.73 |
| Toxic Organic Pollutants Impact | 2021-2025 | 219 | CN 114 | 94.93 |
| Vitamin D Research Studies | 2021-2025 | 191 | CN 9 | 90.25 |
| Climate Change and Health Impacts | 2021-2025 | 655 | CN 179 | 90.80 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 315 | CN 51 | 89.96 |
| Pregnancy and Medication Impact | 2021-2025 | 413 | CN 23 | 83.85 |
| Maternal and Perinatal Health Interventions | 2021-2025 | 968 | CN 20 | 83.35 |
| Preterm Birth and Chorioamnionitis | 2021-2025 | 647 | CN 51 | 65.15 |
| Pregnancy-related medical research | 2021-2025 | 984 | CN 111 | 63.50 |
| Demographic Trends and Gender Preferences | 2021-2025 | 802 | CN 112 | 35.27 |
| Chemical Analysis and Environmental Impact | 2021-2025 | 493 | CN 224 | 24.14 |
